HT
AMLX icon

HAP Trading’s Amylyx Pharmaceuticals AMLX Stock Holding History

HAP Trading’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-197,300
Closed -$402 – 668
2024
Q1 		$402 Buy
+197,300
New +$2.58M ﹤0.01% 685
2023
Q3 		– Sell
-53,400
Closed -$10.7K – 1029
2023
Q2 		$10.7K Buy
+53,400
New +$1.44M ﹤0.01% 807
2022
Q4 		– Sell
-36,700
Closed -$13K – 1498
2022
Q3 		$13K Buy
+36,700
New +$916K ﹤0.01% 1256

Other funds holding AMLX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

HAP Trading's AMLX Position: Q3 2022 in Review

HAP Trading sold out of Amylyx Pharmaceuticals (AMLX) in Q3 2022, closing a stake of 15,322 shares — an estimated $382K sold.

HAP Trading first reported a position in AMLX in Q2 2022 and held it in 1 quarter. The position peaked at $295K in Q2 2022. 95 funds tracked by Wall St. Rank hold AMLX as of Q3 2022.

  • HAP Trading reported no remaining Amylyx Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • HAP Trading sold 15,322 Amylyx Pharmaceuticals shares in Q3 2022, an estimated $382K.
  • HAP Trading first reported a position in Amylyx Pharmaceuticals in Q2 2022 and held it in 1 quarter.
  • HAP Trading's Amylyx Pharmaceuticals position peaked at $295K in Q2 2022.
  • 95 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2022.

Based on HAP Trading's 13F filing for Q3 2022, filed 14 Nov 2022.